Trillium Meditec is developing hydrogel-based therapies for conditions lacking effective treatments. Its lead product, PolyZen, is an injectable hydrogel designed for immediate relief of osteoarthritis joint pain. Future applications include spinal cord injury treatment and broader regenerative medicine uses. The company focuses on advancing innovative, minimally invasive solutions to improve patient outcomes.